Security key
02043Q107
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 130,175,523
- Total 13F shares
- 12,216,380
- Share change
- +576,713
- Total reported value
- $1,825,737,990
- Price per share
- $149.45
- Number of holders
- 2
- Value change
- +$86,189,757
- Number of buys
- 2
Report period
Q1 2024
Institutions
2
Top holders
3
02043Q107 full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
ALNYLAM PHARMACEUTICALS, INC. SEC filings
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of 02043Q107 - Alnylam Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
6.5%
|
8,521,115
|
$1,631,026,620 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
3,118,552
|
$596,922,038 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
66,649
|
$12,757,285 | — | 31 Dec 2023 | |
| Bridgewater Associates, LP |
13F
|
Company |
0%
|
1,951
|
$373,441 | — | 31 Dec 2023 |
Institutional Holders of Alnylam Pharmaceuticals Inc - Common Stock as of Q1 2024
As of 31 Mar 2024,
Alnylam Pharmaceuticals Inc - Common Stock was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,216,380 shares.
The largest 3 holders included
BlackRock Inc., STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
3
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
2
Q1 2024 holders
2
Holder diff
0
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.